Ewart H S, Carroll R, Severson D L
Department of Pharmacology and Therapeutics, Faculty of Medicine, The University of Calgary, AB, Canada.
Can J Physiol Pharmacol. 1999 Aug;77(8):571-8.
Type 1 diabetes mellitus reduces lipoprotein lipase (LPL) activity in the heart. The diabetic phenotype of decreased LPL activity in freshly isolated cardiomyocytes persisted after overnight culture (16 h). Total cellular LPL activity was 311+/-56 nmol oleate released x h(-1) x mg(-1) cell protein in diabetic cultured cardiomyocytes compared with 661+/-81 nmol oleate released x h(-1) x mg(-1) cell protein for control cultured cells. Diabetes also resulted in lower heparin-releasable (HR) LPL activity compared with control cells (111+/-25 vs. 432+/-63 nmol x h(-1) x mg(-1) cell protein). In kinetic experiments, the reduction in total cellular LPL and HR-LPL activities in cultured cells from diabetic hearts was due to a decrease in maximal velocity, with no change in apparent Km for substrate (triolein). LPL activity in primary cultures of cardiomyocytes from control rats is stimulated by the combination of insulin (Ins) and dexamethasone (Dex). Overnight treatment of cultured cardiomyocytes from diabetic rats with Ins+Dex elicited an 84% increase in cellular LPL activity (to 572+/-65 nmol x h(-1) x mg(-1) cell protein) and a 194% increase in HR-LPL activity (to 326+/-46 nmol x h(-1) x mg(-1) cell protein). This stimulation occurred at subnanomolar concentrations of the hormones, but neither hormone was effective alone. The amount of immunoreactive LPL protein mass in cultured cardiomyocytes from diabetic hearts was unchanged by Ins+Dex treatment. Addition of oleic acid (60 microM) to the overnight culture medium inhibited the already reduced HR-LPL activity in diabetic cultured cells by 73% (to 30+/-4 nmol x h(-1) x mg(-1) cell protein). The presence of oleic acid also reduced hormone-stimulated HR-LPL activity. Increasing the glucose concentration in the culture medium to 26 mM had no effect on total cellular LPL or HR-LPL activities.
1型糖尿病会降低心脏中的脂蛋白脂肪酶(LPL)活性。新鲜分离的心肌细胞中LPL活性降低的糖尿病表型在过夜培养(16小时)后依然存在。糖尿病培养心肌细胞中总的细胞LPL活性为每小时每毫克细胞蛋白释放311±56纳摩尔油酸,而对照培养细胞为每小时每毫克细胞蛋白释放661±81纳摩尔油酸。与对照细胞相比,糖尿病还导致肝素可释放(HR)LPL活性降低(分别为111±25和432±63纳摩尔·小时-1·毫克-1细胞蛋白)。在动力学实验中,糖尿病心脏培养细胞中总的细胞LPL和HR-LPL活性降低是由于最大速度降低,而底物(三油酸甘油酯)的表观Km没有变化。对照大鼠心肌细胞原代培养中的LPL活性受到胰岛素(Ins)和地塞米松(Dex)联合作用的刺激。用Ins+Dex对糖尿病大鼠培养的心肌细胞进行过夜处理,可使细胞LPL活性增加84%(达到572±65纳摩尔·小时-1·毫克-1细胞蛋白),HR-LPL活性增加194%(达到326±46纳摩尔·小时-1·毫克-1细胞蛋白)。这种刺激在激素浓度低于纳摩尔时就会出现,但单独一种激素都无效。Ins+Dex处理并未改变糖尿病心脏培养心肌细胞中免疫反应性LPL蛋白的量。向过夜培养基中添加油酸(60微摩尔)可使糖尿病培养细胞中本已降低的HR-LPL活性再降低73%(降至30±4纳摩尔·小时-1·毫克-1细胞蛋白)。油酸的存在也降低了激素刺激的HR-LPL活性。将培养基中的葡萄糖浓度提高到26毫摩尔对总的细胞LPL或HR-LPL活性没有影响。